CaraMed Capital
Overview
CaraMed Capital is a New Zealand-based venture capital firm specializing in deep-health tech investments. The firm focuses on supporting innovative and globally competitive healthtech companies within New Zealand, aiming to foster growth and acceleration in the healthtech sector. By providing access to capital, connections, capability, and global experience, CaraMed Capital seeks to empower local healthtech ventures to thrive in the global market. The firm's investment strategy encompasses a wide range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO. This approach allows them to support companies at various points in their development, from initial concept to market expansion. Their geographical focus is primarily on New Zealand, reflecting a commitment to nurturing the local healthtech ecosystem. CaraMed Capital's industry focus is extensive, covering sectors such as Healthcare, Technology, Biotechnology, Pharmaceuticals, Medical Devices, Digital Health, Health IT, MedTech, Diagnostics, Therapeutics, Health Services, Health Insurance, Health and Wellness, Consumer Health, and Health Research. This broad scope enables the firm to invest in a diverse array of healthtech innovations, contributing to the advancement of the healthcare industry both locally and globally.
Investment Focus
- Innovative healthtech solutions
- Scalable business models
- Strong management teams
- Potential for global impact
Portfolio Companies
Reach CaraMed Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about CaraMed Capital
What sectors does CaraMed Capital invest in?
CaraMed Capital invests in Technology, Healthcare, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in New Zealand. CaraMed Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does CaraMed Capital invest at?
CaraMed Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does CaraMed Capital invest in?
CaraMed Capital invests across New Zealand.
What companies has CaraMed Capital invested in?
CaraMed Capital's portfolio includes Xylo Bio.
How do I contact CaraMed Capital?
CaraMed Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database